Oya Cingöz1, Nicolas D Arnow2, Mireia Puig Torrents2, Norbert Bannert2. 1. Department of Infectious Diseases HIV and Other Retroviruses, Robert Koch Institute, Berlin, Germany. cingoezo@rki.de. 2. Department of Infectious Diseases HIV and Other Retroviruses, Robert Koch Institute, Berlin, Germany.
Abstract
BACKGROUND: The genomes of HIV-2 and some SIV strains contain the accessory gene vpx, which carries out several functions during infection, including the downregulation of SAMHD1. Vpx is also commonly used in experiments to increase HIV-1 infection efficiency in myeloid cells, particularly in studies that investigate the activation of antiviral pathways. However, the potential effects of Vpx on cellular innate immune signaling is not completely understood. We investigated whether and how Vpx affects ISG responses in monocytic cell lines and MDMs during HIV-1 infection. RESULTS: HIV-1 infection at excessively high virus doses can induce ISG activation, although at the expense of high levels of cell death. At equal infection levels, the ISG response is potentiated by the presence of Vpx and requires the initiation of reverse transcription. The interaction of Vpx with the DCAF1 adaptor protein is important for the enhanced response, implicating Vpx-mediated degradation of a host factor. Cells lacking SAMHD1 show similarly augmented responses, suggesting an effect that is independent of SAMHD1 degradation. Overcoming SAMHD1 restriction in MDMs to reach equal infection levels with viruses containing and lacking Vpx reveals a novel function of Vpx in elevating innate immune responses. CONCLUSIONS: Vpx likely has as yet undefined roles in infected cells. Our results demonstrate that Vpx enhances ISG responses in myeloid cell lines and primary cells independently of its ability to degrade SAMHD1. These findings have implications for innate immunity studies in myeloid cells that use Vpx delivery with HIV-1 infection.
BACKGROUND: The genomes of HIV-2 and some SIV strains contain the accessory gene vpx, which carries out several functions during infection, including the downregulation of SAMHD1. Vpx is also commonly used in experiments to increase HIV-1infection efficiency in myeloid cells, particularly in studies that investigate the activation of antiviral pathways. However, the potential effects of Vpx on cellular innate immune signaling is not completely understood. We investigated whether and how Vpx affects ISG responses in monocytic cell lines and MDMs during HIV-1infection. RESULTS:HIV-1infection at excessively high virus doses can induce ISG activation, although at the expense of high levels of cell death. At equal infection levels, the ISG response is potentiated by the presence of Vpx and requires the initiation of reverse transcription. The interaction of Vpx with the DCAF1 adaptor protein is important for the enhanced response, implicating Vpx-mediated degradation of a host factor. Cells lacking SAMHD1 show similarly augmented responses, suggesting an effect that is independent of SAMHD1 degradation. Overcoming SAMHD1 restriction in MDMs to reach equal infection levels with viruses containing and lacking Vpx reveals a novel function of Vpx in elevating innate immune responses. CONCLUSIONS:Vpx likely has as yet undefined roles in infected cells. Our results demonstrate that Vpx enhances ISG responses in myeloid cell lines and primary cells independently of its ability to degrade SAMHD1. These findings have implications for innate immunity studies in myeloid cells that use Vpx delivery with HIV-1infection.
Authors: Anna T Gres; Karen A Kirby; Vineet N KewalRamani; John J Tanner; Owen Pornillos; Stefan G Sarafianos Journal: Science Date: 2015-06-04 Impact factor: 47.728
Authors: Janna Seifried; Stephen Soonthornvacharin; Sunnie M Yoh; Monika Schneider; Rana E Akleh; Kevin C Olivieri; Paul D De Jesus; Chunhai Ruan; Elisa de Castro; Pedro A Ruiz; David Germanaud; Vincent des Portes; Adolfo García-Sastre; Renate König; Sumit K Chanda Journal: Cell Date: 2015-06-04 Impact factor: 41.582
Authors: Nicolas Manel; Brandon Hogstad; Yaming Wang; David E Levy; Derya Unutmaz; Dan R Littman Journal: Nature Date: 2010-09-09 Impact factor: 49.962
Authors: Hisashi Akiyama; Caitlin M Miller; Chelsea R Ettinger; Anna C Belkina; Jennifer E Snyder-Cappione; Suryaram Gummuluru Journal: Nat Commun Date: 2018-08-27 Impact factor: 14.919
Authors: Christine D Landsberg; Dominik A Megger; Dominik Hotter; Meike U Rückborn; Mareike Eilbrecht; Jassin Rashidi-Alavijeh; Sebastian Howe; Stefan Heinrichs; Daniel Sauter; Barbara Sitek; Vu Thuy Khanh Le-Trilling; Mirko Trilling Journal: Front Immunol Date: 2018-12-19 Impact factor: 7.561